Hong Kong stock abnormality | Kangfang Biology (09926.HK) rises more than 6% and plans to repurchase up to HK$200 million in shares. Chairman and executives plan to increase shareholding.
According to the Securities Times APP, Converge Technology BIO (09926.HK) rose more than 6%, as of the time of publication, it rose 5.64% to HK$92.75, with a turnover of HK$797 million.
Latest
